Skip to main content

Public Meeting Schedule: Meeting Details

Meeting Info

Purpose
The purpose of this meeting is to discuss topics associated with SHINE's proposed staggered approach to construction, operation, and licensing of its Medical Isotope Production Facility. Additional topics of discussion are to include SHINE's proposed applications for the receipt of nuclear material prior to operation of the facility.
Meeting Dates and Times
04/13/21, 1PM - 4PM EDT
Meeting Location
Webinar

Contact
Steven Lynch
(301) 415-1524
Participation Level
Observation
NRC Participants
Office of Nuclear Reactor Regulation
Office of Nuclear Material Safety and Safeguards
Office of Nuclear Security and Incident Response
External Participants
SHINE Medical Technologies
Docket Numbers - Facility Names
05000608 - SHINE Medical Technologies, Inc.
Related Documents
ML21096A045 - 04/13/2021 SHINE Medical Technologies, LLC - Discussion of Staggered Approach to Construction, Operation, and Licensing
Teleconference
Bridge Number: 3015762978
Passcode: 23873598#

Page Last Reviewed/Updated Tuesday, April 06, 2021

Page Last Reviewed/Updated Tuesday, April 06, 2021